Reuters logo
BRIEF-Corbus Pharmaceuticals Q3 loss per share $0.14
2017年11月8日 / 下午1点45分 / 13 天前

BRIEF-Corbus Pharmaceuticals Q3 loss per share $0.14

Nov 8 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* Corbus Pharmaceuticals reports 2017 third quarter financial results and highlights recent corporate and clinical advancements

* Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

* Q3 loss per share $0.14

* Corbus Pharmaceuticals Holdings Inc - ‍company expects current cash on hand to fund operations into Q4 of 2019,based on current planned expenditures​

* Corbus Pharmaceuticals Holdings Inc - qtrly revenue $796,312 versus $742,558 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below